MGMT methylation in tissue and serum from unresectable glioblastoma (GBM) patients (p) included in the GENOM 009 study, a multicenter randomized study by the GEINO Group comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV). (ClinicalTrials.gov NCT01102595)
C. Balana
MGMT methylation in tissue and serum from unresectable glioblastoma (GBM) patients (p) included in the GENOM 009 study, a multicenter randomized study by the GEINO Group comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV). (ClinicalTrials.gov NCT01102595)
C. Balana